文献速递炎症性肠病

护理协调干预改善高危炎症性肠病患者症状但未降低费用

A Care Coordination Intervention Improves Symptoms But Not Charges in High-Risk Patients With Inflammatory Bowel Disease.
PubMed 文献 · Clin Gastroenterol Hepatol · 2021-08-28

该随机对照试验纳入预测医疗利用和费用最高五分位的205例炎症性肠病患者,随机分为护理协调干预组(n=100)或常规护理组(n=105),干预为期9个月。结果显示干预组症状评分较常规护理组改善(系数-0.68,95%CI -1.18至-0.18;

要点

  • 护理协调干预可改善高危IBD患者症状评分,但不降低IBD相关费用。
  • 干预由主动症状监测和护理协调员触发算法组成,为期9个月。
  • 研究纳入预测医疗利用和费用最高五分位的IBD患者。

核心结论

  • 在预测医疗利用和费用最高五分位的IBD患者中,护理协调干预改善了症状评分但未显著改变IBD相关费用。

研究设计与样本

  • 随机对照试验,纳入205例预测医疗利用和费用最高五分位的IBD患者,随机分为护理协调干预组(n=100)和常规护理组(n=105),干预为期9个月(2019年4月至2020年1月)。

临床怎么用

  • 护理协调项目可能作为基于价值的策略,在高危IBD患者中改善症状评分而不增加直接费用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Inflammatory bowel disease (IBD) is associated with substantial symptom burden, variability in clinical outcomes, and high direct costs. We sought to determine if a care coordination-based strategy was effective at improving patient symptom burden and reducing healthcare costs for patients with IBD in the top quintile of predicted healthcare utilization and costs. METHODS: We performed a randomized controlled trial to evaluate the efficacy of a patient-tailored multicomponent care coordination intervention composed of proactive symptom monitoring and care coordinator-triggered algorithms. Enrolled patients with IBD were randomized to usual care or to our care coordination intervention over a 9-month period (April 2019 to January 2020). Primary outcomes included change in patient symptom scores throughout the intervention and IBD-related charges at 12 months. RESULTS: Eligible IBD patients in the top quintile for predicted healthcare utilization and expenditures were identified. A total of 205 patients were enrolled and randomized to our intervention (n = 100) or to usual care (n = 105). Patients in the care coordinator arm demonstrated an improvement in symptoms scores compared with usual care (coefficient, -0.68, 95% confidence interval, -1.18 to -0.18; P = .008) without a significant difference in median annual IBD-related healthcare charges ($10,094 vs $9080; P = .322). CONCLUSIONS: In this first randomized controlled trial of a patient-tailored care coordination intervention, composed of proactive symptom monitoring and care coordinator-triggered algorithms, we observed an improvement in patient symptom scores but not in healthcare charges. Care coordination programs may represent an effective value-based approach to improve symptoms scores without added direct costs in a subgroup of high-risk patients with IBD. (ClinicalTrials.gov, Number: NCT04796571).

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Berinstein JA, Cohen-Mekelburg SA, Greenberg GM, et al. A Care Coordination Intervention Improves Symptoms But Not Charges in High-Risk Patients With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2021. PMID: 34461298. doi:10.1016/j.cgh.2021.08.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。